fda bpc 157 category 2 compounding 2023 Peptide Therapy After the Decision: A Readiness Guide FDA PCAC Meeting: Preparing for
Description
Based on this review, the authors conclude (p
[DOI] [PMC free article] [PubMed] [Google Scholar] 750
Dissolve in SWFI or BAC water
The most common side effect is temporary mild irritation at the injection site
Jiang et al
